EyePoint Pharmaceuticals Inc
NASDAQ:EYPT

Watchlist Manager
EyePoint Pharmaceuticals Inc Logo
EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
Watchlist
Price: 5.9 USD 3.96% Market Closed
Market Cap: 405.5m USD

Intrinsic Value

EYPT's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one EYPT stock under the Base Case scenario is 3.89 USD. Compared to the current market price of 5.9 USD, EyePoint Pharmaceuticals Inc is Overvalued by 34%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

EYPT Intrinsic Value
3.89 USD
Overvaluation 34%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
EyePoint Pharmaceuticals Inc

EYPT
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for EYPT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

EyePoint Pharmaceuticals Inc
NASDAQ:EYPT
US
Pharmaceuticals
Market Cap
402.8m USD
IPO
Jan 27, 2005
US
Pharmaceuticals
Market Cap
402.8m USD
IPO
Jan 27, 2005
Price
$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about EYPT?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about EyePoint Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
EyePoint Pharmaceuticals Inc

Current Assets 383.3m
Cash & Short-Term Investments 370.9m
Receivables 607k
Other Current Assets 11.8m
Non-Current Assets 35.2m
PP&E 29.2m
Other Non-Current Assets 6m
Efficiency

Free Cash Flow Analysis
EyePoint Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
EyePoint Pharmaceuticals Inc

Revenue
43.3m USD
Cost of Revenue
-3.7m USD
Gross Profit
39.6m USD
Operating Expenses
-185.4m USD
Operating Income
-145.9m USD
Other Expenses
15m USD
Net Income
-130.9m USD
Fundamental Scores

EYPT Profitability Score
Profitability Due Diligence

EyePoint Pharmaceuticals Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

48/100
Profitability
Score

EyePoint Pharmaceuticals Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

EYPT Solvency Score
Solvency Due Diligence

EyePoint Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

EyePoint Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

EYPT Price Targets Summary
EyePoint Pharmaceuticals Inc

Wall Street analysts forecast EYPT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EYPT is 33.66 USD with a low forecast of 18.18 USD and a high forecast of 71.4 USD.

Lowest
Price Target
18.18 USD
208% Upside
Average
Price Target
33.66 USD
471% Upside
Highest
Price Target
71.4 USD
1 110% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

EyePoint Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for EYPT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

EYPT Insider Trading
Buy and sell transactions by insiders

EYPT News

What is the Intrinsic Value of one EYPT stock?

The intrinsic value of one EYPT stock under the Base Case scenario is 3.89 USD.

Is EYPT stock undervalued or overvalued?

Compared to the current market price of 5.9 USD, EyePoint Pharmaceuticals Inc is Overvalued by 34%.

Back to Top